215 related articles for article (PubMed ID: 23935930)
1. Plasma 25-hydroxyvitamin D and its genetic determinants in relation to incident myocardial infarction and stroke in the European prospective investigation into cancer and nutrition (EPIC)-Germany study.
Kühn T; Kaaks R; Teucher B; Hirche F; Dierkes J; Weikert C; Katzke V; Boeing H; Stangl GI; Buijsse B
PLoS One; 2013; 8(7):e69080. PubMed ID: 23935930
[TBL] [Abstract][Full Text] [Related]
2. Plasma 25-hydroxyvitamin D and its genetic determinants in relation to incident type 2 diabetes: a prospective case-cohort study.
Buijsse B; Boeing H; Hirche F; Weikert C; Schulze MB; Gottschald M; Kühn T; Katzke VA; Teucher B; Dierkes J; Stangl GI; Kaaks R
Eur J Epidemiol; 2013 Sep; 28(9):743-52. PubMed ID: 24002339
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms related to the serum 25-hydroxyvitamin D level and risk of myocardial infarction, diabetes, cancer and mortality. The Tromsø Study.
Jorde R; Schirmer H; Wilsgaard T; Joakimsen RM; Mathiesen EB; Njølstad I; Løchen ML; Figenschau Y; Berg JP; Svartberg J; Grimnes G
PLoS One; 2012; 7(5):e37295. PubMed ID: 22649517
[TBL] [Abstract][Full Text] [Related]
4. No evidence that genetically reduced 25-hydroxyvitamin D is associated with increased risk of ischaemic heart disease or myocardial infarction: a Mendelian randomization study.
Brøndum-Jacobsen P; Benn M; Afzal S; Nordestgaard BG
Int J Epidemiol; 2015 Apr; 44(2):651-61. PubMed ID: 25981321
[TBL] [Abstract][Full Text] [Related]
5. Exploring the genetic architecture of circulating 25-hydroxyvitamin D.
Hiraki LT; Major JM; Chen C; Cornelis MC; Hunter DJ; Rimm EB; Simon KC; Weinstein SJ; Purdue MP; Yu K; Albanes D; Kraft P
Genet Epidemiol; 2013 Jan; 37(1):92-8. PubMed ID: 23135809
[TBL] [Abstract][Full Text] [Related]
6. A Reverse J-Shaped Association Between Serum 25-Hydroxyvitamin D and Cardiovascular Disease Mortality: The CopD Study.
Durup D; Jørgensen HL; Christensen J; Tjønneland A; Olsen A; Halkjær J; Lind B; Heegaard AM; Schwarz P
J Clin Endocrinol Metab; 2015 Jun; 100(6):2339-46. PubMed ID: 25710567
[TBL] [Abstract][Full Text] [Related]
7. Estimating dose-response relationships for vitamin D with coronary heart disease, stroke, and all-cause mortality: observational and Mendelian randomisation analyses.
Emerging Risk Factors Collaboration/EPIC-CVD/Vitamin D Studies Collaboration
Lancet Diabetes Endocrinol; 2021 Dec; 9(12):837-846. PubMed ID: 34717822
[TBL] [Abstract][Full Text] [Related]
8. Estimating dose-response relationships for vitamin D with coronary heart disease, stroke, and all-cause mortality: observational and Mendelian randomisation analyses.
Emerging Risk Factors Collaboration/EPIC-CVD/Vitamin D Studies Collaboration
Lancet Diabetes Endocrinol; 2024 Jan; 12(1):e2-e11. PubMed ID: 38048800
[TBL] [Abstract][Full Text] [Related]
9. Circulating 25-hydroxyvitamin D concentration and the risk of type 2 diabetes: results from the European Prospective Investigation into Cancer (EPIC)-Norfolk cohort and updated meta-analysis of prospective studies.
Forouhi NG; Ye Z; Rickard AP; Khaw KT; Luben R; Langenberg C; Wareham NJ
Diabetologia; 2012 Aug; 55(8):2173-82. PubMed ID: 22526608
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D, vitamin D binding protein gene polymorphisms, race and risk of incident stroke: the Atherosclerosis Risk in Communities (ARIC) study.
Schneider AL; Lutsey PL; Selvin E; Mosley TH; Sharrett AR; Carson KA; Post WS; Pankow JS; Folsom AR; Gottesman RF; Michos ED
Eur J Neurol; 2015 Aug; 22(8):1220-7. PubMed ID: 25962507
[TBL] [Abstract][Full Text] [Related]
11. The association between circulating 25-hydroxyvitamin D metabolites and type 2 diabetes in European populations: A meta-analysis and Mendelian randomisation analysis.
Zheng JS; Luan J; Sofianopoulou E; Sharp SJ; Day FR; Imamura F; Gundersen TE; Lotta LA; Sluijs I; Stewart ID; Shah RL; van der Schouw YT; Wheeler E; Ardanaz E; Boeing H; Dorronsoro M; Dahm CC; Dimou N; El-Fatouhi D; Franks PW; Fagherazzi G; Grioni S; Huerta JM; Heath AK; Hansen L; Jenab M; Jakszyn P; Kaaks R; Kühn T; Khaw KT; Laouali N; Masala G; Nilsson PM; Overvad K; Olsen A; Panico S; Quirós JR; Rolandsson O; Rodríguez-Barranco M; Sacerdote C; Spijkerman AMW; Tong TYN; Tumino R; Tsilidis KK; Danesh J; Riboli E; Butterworth AS; Langenberg C; Forouhi NG; Wareham NJ
PLoS Med; 2020 Oct; 17(10):e1003394. PubMed ID: 33064751
[TBL] [Abstract][Full Text] [Related]
12. Racial/Ethnic Differences in 25-Hydroxy Vitamin D and Parathyroid Hormone Levels and Cardiovascular Disease Risk Among Postmenopausal Women.
Zhang X; Tu W; Manson JE; Tinker L; Liu S; Cauley JA; Qi L; Mouton C; Martin LW; Hou L; Song Y
J Am Heart Assoc; 2019 Feb; 8(4):e011021. PubMed ID: 30764690
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D-related genes, serum vitamin D concentrations and prostate cancer risk.
Ahn J; Albanes D; Berndt SI; Peters U; Chatterjee N; Freedman ND; Abnet CC; Huang WY; Kibel AS; Crawford ED; Weinstein SJ; Chanock SJ; Schatzkin A; Hayes RB;
Carcinogenesis; 2009 May; 30(5):769-76. PubMed ID: 19255064
[TBL] [Abstract][Full Text] [Related]
14. Associations of serum 25-hydroxyvitamin D and vitamin D receptor polymorphisms with risks of cardiovascular disease and mortality among patients with chronic kidney disease: a prospective study.
Zhao S; Chen X; Wan Z; Geng T; Lu Q; Yu H; Lin X; Pan A; Liu G
Am J Clin Nutr; 2024 Jun; 119(6):1397-1404. PubMed ID: 38608754
[TBL] [Abstract][Full Text] [Related]
15. Association of polymorphisms in the CRP gene with circulating C-reactive protein levels and cardiovascular events.
Lange LA; Carlson CS; Hindorff LA; Lange EM; Walston J; Durda JP; Cushman M; Bis JC; Zeng D; Lin D; Kuller LH; Nickerson DA; Psaty BM; Tracy RP; Reiner AP
JAMA; 2006 Dec; 296(22):2703-11. PubMed ID: 17164456
[TBL] [Abstract][Full Text] [Related]
16. Serum 25-hydroxyvitamin D and incidence of fatal and nonfatal cardiovascular events: a prospective study with repeated measurements.
Perna L; Schöttker B; Holleczek B; Brenner H
J Clin Endocrinol Metab; 2013 Dec; 98(12):4908-15. PubMed ID: 24106288
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D and prognosis in acute myocardial infarction.
Ng LL; Sandhu JK; Squire IB; Davies JE; Jones DJ
Int J Cardiol; 2013 Oct; 168(3):2341-6. PubMed ID: 23415169
[TBL] [Abstract][Full Text] [Related]
18. Serum 25-hydroxyvitamin D concentration and risk for major clinical disease events in a community-based population of older adults: a cohort study.
de Boer IH; Levin G; Robinson-Cohen C; Biggs ML; Hoofnagle AN; Siscovick DS; Kestenbaum B
Ann Intern Med; 2012 May; 156(9):627-34. PubMed ID: 22547472
[TBL] [Abstract][Full Text] [Related]
19. Associations between incident ischemic stroke events and stroke and cardiovascular disease-related genome-wide association studies single nucleotide polymorphisms in the Population Architecture Using Genomics and Epidemiology study.
Carty CL; Buzková P; Fornage M; Franceschini N; Cole S; Heiss G; Hindorff LA; Howard BV; Mann S; Martin LW; Zhang Y; Matise TC; Prentice R; Reiner AP; Kooperberg C
Circ Cardiovasc Genet; 2012 Apr; 5(2):210-6. PubMed ID: 22403240
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D status, genetic factors, and risks of cardiovascular disease among individuals with type 2 diabetes: a prospective study.
Wan Z; Geng T; Li R; Chen X; Lu Q; Lin X; Chen L; Guo Y; Liu L; Shan Z; Pan A; Manson JE; Liu G
Am J Clin Nutr; 2022 Nov; 116(5):1389-1399. PubMed ID: 35771998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
